CNN Profiles - Nectar Gan - Digital Producer - CNN

Edition

Edition

Follow CNN

BEIJING, CHINA - SEPTEMBER 24: A technician works in a lab at Sinovac Biotech where the company is producing their potential COVID-19 vaccine CoronaVac during a media tour on September 24, 2020 in Beijing, China. Sinovacs inactivated vaccine candidate, called CoronaVac, is among a number of companies in the global race to control the coronavirus pandemic. The company is running Phase 3 human trials in four countries and ramping up production to 300 million doses per year at a new manufacturing facility south of Beijing. A lack of domestic coronavirus cases in China has meant that companies developing vaccines have shifted their focus overseas to conduct trials to gather the volume of data necessary to win regulatory approvals. When Chinas government launched an emergency use program in July to vaccinate groups of essential workers, Sinovacs chief executive says the company supplied tens of thousands of doses, even as trials are still underway. About 90% of Sinovacs employees have chosen to receive injections of CoronaVac, which is one of eight Chinese vaccine candidates in human trials. The company is also seeking approval to begin clinical trials with teenagers and children as young as age 3.(Photo by Kevin Frayer/Getty Images)

China is doubling down in the global push for a coronavirus vaccine

QINGDAO, CHINA - OCTOBER 03: (CHINA OUT) The Zhan Qiao is crammed with tourists on the third day of the National Day holiday on Ocober 3, 2014 in Qingdao, China. China's golden-week National Day holiday is expected to bring a tourism peak throughout the country. (Photo by VCG/VCG via Getty Images)

China contained Covid-19. Now, hundreds of millions of people there are about to go on vacation at the same time

BEIJING, CHINA - SEPTEMBER 05: An employee displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), during the 2020 China International Fair for Trade in Services (CIFTIS) at Beijing Olympic Park on September 5, 2020 in Beijing, China. As China recovers from the COVID-19 epidemic, about 2,000 Chinese and foreign enterprises will participate and showcase their newest technology in public health and digital technology in the China International Fair for Trade in Services. (Photo by Lintao Zhang/Getty Images)

China says it got WHO support for coronavirus vaccine emergency use

This scanning electron microscope image shows SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S., emerging from the surface of cells (gray) cultured in the lab. Credit: NIAID-RML